Strata Critical Medical, Inc.

Strata Critical Medical, Inc. is a U.S.-based time-critical logistics and medical services company focused on the transplant ecosystem. Through its Trinity Medical Solutions and Keystone Perfusion Services brands, it provides air and ground organ transport, organ placement, surgical organ recovery, normothermic regional perfusion, and perfusion staffing and equipment support.

−7,2 %

20,9 %

21,0 %

−20,7 %

6.38

6.38

— Strata Critical Medical, Inc.
%
Transplant logistics45% Air and ground transport, scheduling, and chain-of-custody services for organ recovery and transplant.
Organ placement services15% Administrative support for evaluating donor organs and coordinating acceptance decisions.
Clinical transplant services25% Surgical organ recovery, normothermic regional perfusion, and related clinical support.
Perfusion staffing and equipment15% Staffing and equipment solutions for cardiovascular surgery centers and hospitals.

Strata sells directly to transplant centers, organ procurement organizations, hospitals, and other healthcare...

  • Transplant centersprimary

    Buy organ transport, placement, recovery, and NRP services to increase transplant throughput and reduce coordination burden.

  • Organ Procurement Organizations (OPOs)primary

    Use surgical recovery, preservation, and logistics services to manage donor organ recovery and delivery.

  • Hospitals and health systemssecondary

    Purchase perfusion staffing, equipment, and related clinical support for cardiac surgery and transplant cases.

  • Cardiovascular surgery centerssecondary

    Buy perfusion personnel and equipment on a contractual basis for operating-room support.

Strata’s business is concentrated in the United States, where it operates a nationwide network for transplant logistics...

  • United States is the core market for all services
  • Nationwide network supports urgent organ transport and recovery
  • Operations depend on aircraft access across many U.S. locations
  • Local clinical resources help reduce incremental logistics costs
  • Geography matters because transplant cases are time-critical

Strata’s strategy is to offer an integrated “one call” solution that combines logistics and clinical services around...

01
Integrated transplant platformmedium-term

Combining transport, recovery, placement, and perfusion improves customer convenience and differentiation.

02
Service expansion around transplant workflowsmedium-term

Adjacent services increase share of wallet and make the company more embedded in the transplant ecosystem.

03
Technology-enabled executionshort-term

Software and tracking tools support reliability, compliance, and coordination in time-sensitive cases.

Strata depends on winning and retaining medical customers in a highly competitive, time-critical market where service...

high

Customer concentration and retention in transplant logistics

Revenue depends on securing medical customers and expanding services with existing accounts.

Scope
Transplant centers, OPOs, hospitals
Materiality
high
high

Operational failure in time-critical transport

Organ cases require rapid dispatch, aircraft availability, and precise coordination.

Scope
Air and ground logistics
Materiality
high
high

Technology and cybersecurity disruption

Logistics coordination, data tracking, and customer interfaces are essential to service delivery.

Scope
Cloud-hosted systems and chain-of-custody tools
Materiality
high
high

Clinical liability and reputational damage

Surgical recovery, perfusion, and NRP services can lead to claims, investigations, or negative publicity.

Scope
Clinical segment
Materiality
high
medium

Competition from bundled device and logistics providers

Organ preservation equipment makers may also offer transport and clinical services.

Scope
Transplant ecosystem
Materiality
medium
Revenue recognition by contract type
Timing and quarterly comparability
Business combinations and contingent consideration
Purchase accounting, liabilities, and earnings volatility
Stock-based compensation
Non-cash expense and dilution
Goodwill and intangible asset impairment
Potential non-cash write-downs

: 29/04/2026